CLINICAL_TRIALS
trial_result
· 2017-05-12
Clinical Trial Update: A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer [Phase 1, Phase 2]
Summary
Phase I/II trial evaluating ADXS11-001 with mitomycin, 5-FU, and IMRT for anal cancer; study terminated with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Brown University | Conditions: Anal Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-05-12